A Look inside the "Doughnut Hole": How Drug-Benefit Limits Affect Retiree Prescription Use
Publication Date: January 2007
Publisher(s): RAND Corporation
Author(s): Geoffrey F. Joyce; Dana P. Goldman; Pinar Karaca-Mandic
Funder(s): RAND Corporation
Funder(s): RAND Corporation
Topic: Health (Pharmaceutical services)
Abstract:
This research brief examines the likely effects of the gap in the Medicare Part D standard drug benefit after $2,400 in pharmaceutical spending, using data from a private employer.
Sign up to receive email newsletters about the
latest research for the topic areas that
interest you.